Concepedia

Michael Rudloff

MR

6

Publications

255

Citations

6

H-Index

2015

Active since

Affiliations

Vanderbilt University Medical Center(Current)

James Madison University

Center for Cancer Research

Michael Rudloff is an author at Vanderbilt University Medical Center specializing in cell biology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2015–2023

6

Publications

6

Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division

Michael Rudloff, Paul Zumbo, Natalie R. Favret et al. · Nature Immunology · 2023 · 112 citations · Full text

, , +10

Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases

Leela Rani Avula, Michael Rudloff, Salma El-Behaedi et al. · Molecular Cancer Research · 2019 · 49 citations · Full text

Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway

Maegen A. Ackermann, Brendan King, Nicole A. P. Lieberman et al. · Journal of Molecular and Cellular Cardiology · 2017 · 32 citations · Full text

, , +10

Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes

Emily Kolyvas, Michael Rudloff, Marianne S. Poruchynsky et al. · Oncotarget · 2016 · 26 citations · Full text

, , +18

Biophysical characterization of naturally occurring titin M10 mutations

Michael Rudloff, Alec N. Woosley, Nathan T. Wright · Protein Science · 2015 · 25 citations · Full text

, , +14

Rows per page

1–5 of 6